Metenolone Acetate may be available in the countries listed below.
Metenolone Acetate (BANM) is also known as Metenolone (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
ratio-Tamsulosin may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of ratio-Tamsulosin in the following countries:
International Drug Name Search
Ranidura may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranidura in the following countries:
International Drug Name Search
Generic Name: damiana (dah mee AH na)
Brand Names:
The use of damiana in cultural and traditional settings may differ from concepts accepted by current Western medicine. When considering the use of herbal supplements, consultation with a primary health care professional is advisable. Additionally, consultation with a practitioner trained in the uses of herbal/health supplements may be beneficial, and coordination of treatment among all health care providers involved may be advantageous.
Damiana is also known as Turnera diffusa, Mexican damiana, old woman's broom, and herba de la pastora.
Damiana has been used as an aphrodisiac, to treat headaches, and to aid in the control of bed wetting.
Damiana has not been evaluated by the FDA for safety, effectiveness, or purity. All potential risks and/or advantages of damiana may not be known. Additionally, there are no regulated manufacturing standards in place for these compounds. There have been instances where herbal/health supplements have been sold which were contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.
Damiana may also have uses other than those listed in this product guide.
take a medicine to treat diabetes or to control blood sugar levels such as insulin, glipizide (Glucotrol), glyburide (Micronase, Glynase, Diabeta), tolbutamide (Orinase), metformin (Glucophage), acarbose (Precose), troglitazone (Rezulin), pioglitazone (Actos), rosiglitazone (Avandia), and others;
have a history of breast cancer;
have a psychiatric disorder such as mania or schizophrenia;
have Alzheimer's disease; or
have Parkinson's disease.
The use of damiana may be dangerous if you have any of the conditions listed above.
Damiana has not been evaluated by the FDA for safety, effectiveness, or purity. All potential risks and/or advantages of damiana may not be known. Additionally, there are no regulated manufacturing standards in place for these compounds. There have been instances where herbal/health supplements have been sold which were contaminated with toxic metals or other drugs. Herbal/health supplements should be purchased from a reliable source to minimize the risk of contamination.
take a medicine to treat diabetes or to control blood sugar levels such as insulin, glipizide (Glucotrol), glyburide (Micronase, Glynase, Diabeta), tolbutamide (Orinase), metformin (Glucophage), acarbose (Precose), troglitazone (Rezulin), pioglitazone (Actos), rosiglitazone (Avandia), and others;
have a history of breast cancer;
have a psychiatric disorder such as mania or schizophrenia;
have Alzheimer's disease; or
have Parkinson's disease.
The use of damiana may be dangerous if you have any of the conditions listed above.
Before taking damiana, talk to your doctor, pharmacist, or health care professional if you have allergies (especially to plants), have any medical condition, or if you take other medicines or other herbal/health supplements. Damiana may not be recommended in some situations.
The use of damiana in cultural and traditional settings may differ from concepts accepted by current Western medicine. When considering the use of herbal supplements, consultation with a primary health care professional is advisable. Additionally, consultation with a practitioner trained in the uses of herbal/health supplements may be beneficial, and coordination of treatment among all health care providers involved may be advantageous.
If you choose to take damiana, use it as directed on the package or as directed by your doctor, pharmacist, or other health care provider.
Standardized extracts, tinctures, and solid formulations of herbal/health supplements may provide a more reliable dose of the product.
To ensure the correct dose, measure the liquid forms of damiana with a dropper or a dose-measuring spoon or cup.
Some forms of damiana may be brewed to form a tea for drinking.
Store damiana as directed on the package. In general, damiana should be protected from light.
Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra damiana to make up the missed dose.
Follow your healthcare provider's instructions about any restrictions on food, beverages, or activity.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Interactions between damiana and other prescription or over-the-counter medicines or herbal/health supplements may also occur. Talk to your doctor, pharmacist, or health care professional before taking damiana if you are taking any other medicines or supplements.
Aviant may be available in the countries listed below.
Desloratadine is reported as an ingredient of Aviant in the following countries:
International Drug Name Search
Parexat may be available in the countries listed below.
Paroxetine is reported as an ingredient of Parexat in the following countries:
International Drug Name Search
DuoTrav may be available in the countries listed below.
UK matches:
Timolol is reported as an ingredient of DuoTrav in the following countries:
Timolol maleate (a derivative of Timolol) is reported as an ingredient of DuoTrav in the following countries:
Travoprost is reported as an ingredient of DuoTrav in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Dedile may be available in the countries listed below.
Flutamide is reported as an ingredient of Dedile in the following countries:
International Drug Name Search
Class Name: radiopharmaceutical (Oral route)
In the U.S.
Available Dosage Forms:
Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. They may be given to the patient in several different ways. For example, they may be given by mouth, given by injection, or placed into the eye or into the bladder.
These radiopharmaceuticals are used in the diagnosis of:
Radiopharmaceuticals are radioactive agents. However, when small amounts are used, the radiation your body receives from them is very low and is considered safe. When larger amounts of these agents are given to treat disease, there may be different effects on the body.
When radiopharmaceuticals are used to help diagnose medical problems, only small amounts are given to the patient. The radiopharmaceutical then passes through, or is taken up by, an organ of the body (which organ depends on what radiopharmaceutical is used and how it has been given). Then the radioactivity is detected, and pictures are produced, by special imaging equipment. These pictures allow the nuclear medicine doctor to study how the organ is working and to detect cancer or tumors that may be present in the organ.
Some radiopharmaceuticals are used in larger amounts to treat certain kinds of cancer and other diseases. In those cases, the radioactive agent is taken up in the cancerous area and destroys the affected tissue. The information that follows applies only to radiopharmaceuticals when used in small amounts to diagnose medical problems.
The dosages of radiopharmaceuticals that are used to diagnose medical problems will be different for different patients and depend on the type of test. The amount of radioactivity of a radiopharmaceutical is expressed in units called becquerels or curies. Radiopharmaceutical dosages given may be as small as 0.185 megabecquerels (5 microcuries) or as high as 1295 megabecquerels (35 millicuries). The radiation received from these dosages may be about the same as, or even less than, the radiation received from an x-ray study of the same organ.
Radiopharmaceuticals are to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.
OncoScint(R) CR/CV (satumomab pendetide) was discontinued in the United States on December 26, 2002.
Marketing of NeutroSpec (technetium 99m TC fanolesomab) was discontinued by Palatin Technologies, their marketing partner, Mallinckrodt, and the FDA. The risk of severe and fatal allergic-type reactions outweigh its benefit.
In deciding to receive a diagnostic test, the risks of taking the test must be weighed against the good it will do. This is a decision you and your doctor will make. For these tests, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
For most radiopharmaceuticals, the amount of radiation used for a diagnostic test is very low and considered safe. However, be sure you have discussed with your doctor the benefit versus the risk of exposing your child to radiation.
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. Although there is no specific information comparing use of most radiopharmaceuticals in the elderly with use in other age groups, problems would not be expected to occur. However, it is a good idea to check with your doctor if you notice any unusual effects after receiving a radiopharmaceutical.
Radiopharmaceuticals usually are not recommended for use during pregnancy. This is to avoid exposing the fetus to radiation. Some radiopharmaceuticals may be used for diagnostic tests in pregnant women, but it is necessary to inform your doctor if you are pregnant so the doctor may reduce the radiation dose to the baby. This is especially important with radiopharmaceuticals that contain radioactive iodine, which can go to the baby's thyroid gland and, in high enough amounts, may cause thyroid damage. Be sure you have discussed this with your doctor.
Some radiopharmaceuticals pass into the breast milk and may expose the baby to radiation. If you must receive a radiopharmaceutical, it may be necessary for you to stop breast-feeding for some time after receiving it. Be sure you have discussed this with your doctor.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The nuclear medicine doctor may have special instructions for you in preparation for your test. For example, before some tests you must fast for several hours, or the results of the test may be affected. For other tests you should drink plenty of liquids. If you do not understand the instructions you receive or if you have not received any instructions, check with the nuclear medicine doctor in advance.
There are usually no special precautions to observe for radiopharmaceuticals when they are used in small amounts for diagnosis.
Some radiopharmaceuticals may accumulate in your bladder. Therefore, to increase the flow of urine and lessen the amount of radiation to your bladder, your doctor may instruct you to drink plenty of liquids and urinate often after certain tests.
For patients receiving radioactive iodine (iodohippurate sodium I 123, iodohippurate sodium I 131, iofetamine I 123, iothalamate I 125, radioiodinated albumin, or radioiodinated iobenguane):
Along with its needed effects, a medicine may cause some unwanted effects. When radiopharmaceuticals are used in very small doses to study an organ of the body, side effects are rare and usually involve an allergic reaction. These effects may occur almost immediately or a few minutes after the radiopharmaceutical is given. It may be helpful to note the time when you first notice any side effect. Your doctor, nuclear medicine physician and/or technologist, or nurse will be prepared to give you immediate medical attention if needed.
Check with your doctor or nurse immediately if any of the following side effects occur:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Healthcare (Micromedex) products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Healthcare does not assume any responsibility or risk for your use of the Thomson Healthcare products.
Ranbex may be available in the countries listed below.
Ranitidine is reported as an ingredient of Ranbex in the following countries:
International Drug Name Search
Röwo Vitamin-B12 may be available in the countries listed below.
Cyanocobalamin is reported as an ingredient of Röwo Vitamin-B12 in the following countries:
International Drug Name Search
Hydopa may be available in the countries listed below.
Methyldopa is reported as an ingredient of Hydopa in the following countries:
International Drug Name Search
Econazole Mylan may be available in the countries listed below.
Econazole nitrate (a derivative of Econazole) is reported as an ingredient of Econazole Mylan in the following countries:
International Drug Name Search
Suprein may be available in the countries listed below.
Nimesulide is reported as an ingredient of Suprein in the following countries:
International Drug Name Search
